Hematologic disorders associated with deletions of chromosome 20q: A clinicopathologic study of 107 patients

American Journal of Clinical Pathology

Volumn 106, Issue 5, 1996, Pages 680-688

  Kurtin, Paul J ^a   Dewald, Gordon W ^a   Shields, David J ^a   Hanson, Curtis A ^a  

^a MAYO CLINIC   (United States)

Author keywords

Acute leukemia; Bone marrow; Cytogenetics; Del(20q); Myelodysplastic syndromes; Myeloproliferative disorders

Indexed keywords

ACUTE GRANULOCYTIC LEUKEMIA; ANGIOIMMUNOBLASTIC LYMPHADENOPATHY; ARTICLE; CHROMOSOME 20Q; CHROMOSOME DELETION; DYSPROTEINEMIA; HEMATOLOGIC DISEASE; HUMAN; HUMAN CELL; MEGAKARYOCYTE; PRIORITY JOURNAL; STEM CELL; T CELL LYMPHOMA;

EID: 0029846342     PISSN: 00029173     EISSN: None     Source Type: Journal    
DOI: 10.1093/ajcp/106.5.680     Document Type: Article

References (63)

1. Kay HEM, Lawler SD, Millard RE. The chromosomes in polycythaemia vera. Br J Haematol 1966; 12:507-527.
2. Reeves BR, Lobb DS, Lawler SD. Identity of the abnormal F-group chromosome associated with polycythemia vera. Hum Genet 1972;14:159-161.
3. Mertens F, Johansson B, Heim S, Kristofferson U, Mitelman F. Karyotypic patterns in chronic myeloproliferative disorders: Report on 74 cases and review of the literature. Leukemia 1991;5:214-220.
4. Diez-Martin JL, Graham DL, Petitt RM. Dewald GW. Chromosome studies in 104 patients with polycythemia vera. Mayo Clin Proc 1991;66:287-299.
5. Rege-Cambrin G, Mecucci C, Tricot G, et al. A chromosomal profile of polycythemia vera. Cancer Genet Cytogenet 1987;25: 233-245.
6. Swolin B, Weinfeld A. Westin J. A prospective long-term cytogenetic study in polycythemia vera in relation to treatment and clinical course. Blood 1988;72:386-395.
7. Zech L, Garhton C, Killander D, Franzen S, Haglund U. Specific chromosomal aberrations in polycythemia vera. Blood 1976;48: 687-697.
8. Westin J, WahlstrÜm J, Swolin B. Chromosome studies in untreated polycythaemia vera. Scand J Haematol 1976;17:183-196.
9. Berger R, Bernheim A, Le Coniat M, et al. Chromosome studies in polycythemia vera patients. Cancer Genet Cytogenet 1984; 12: 217-223.
10. Aatola M, Armstrong E, Teerenhovi L, BorgstrÜm GH. Clinical significance of the del(20q) chromosome in hematologic disorders. Cancer Genet Cytogenet 1992;62:75-80.
11. Davis MP, Dewald GD, Pierre RV, Hoagland HC. Hematologic manifestations associated with deletions of the long arm of chrmomsome 20. Cancer Genet Cytogenet 1984;12:63-71.
12. Kirkland DJ, Welch SG, Povey S, Najfeld V, Price DJ, Lawler SD. Glutamic pyruvate transaminase phenotypes in polycythaemia rubra vera. Br J Haematol 1980;44:407-413.
13. Jarosova M, Indrak K, Dusek J, Kapustova M. Cytogenetic studies in polycythemia vera. Neoplasma 1988;35:221-228.
14. Groupe FDCH. Cytogenetics of acutely transformed chronic myeloproliferative syndromes without a Philadelphia chromosome: A multicenter study of 55 patients. Cancer Genet Cytogenet 1988;32:157-168.
15. Miller JB, Testa JR, Lindgren V, Rowley JD. The pattern and clinical significance of karyotypic abnormalities in patients with idiopathic and postpolycythemic myelofibrosis. Cancer 1985;55: 582-591.
16. Campbell LJ, Garson OM. The prognostic significance of deletion of the long arm of chromosome 20 in myeloid disorders. Leukemia 1994;8:61-71.
17. Nowell PC, Besa EC. Prognostic significance of single chromosome abnormalities in preleukemic states. Cancer Genet Cytogenet 1989;42:1-7.
18. Demory JL, Dupriez B, Fenaux P, et al. Cytogenetic studies and their prognostic significance in agnogenic myeloid metaplasia: A report on 47 cases. Blood 1988;72:855-859.
19. Sessarego M, Defferrari R, Dejana AM, et al. Cytogenetic analysis in essential thrombocythemia at diagnosis and at transformation: A 12-year study. Cancer Genet Cytogenet 1989;43:57-65.
20. Morel P, Hebbar M, Lai J-L, et al. Cytogenetic analysis has strong independent prognostic value in de novo myelodysplastic syndromes and can be incorporated in a new scoring system: A report on 408 cases. Leukemia 1993;7:1315-1323.
21. Wattel E, Lai JL, Hebbar M, et al. De novo myelodysplastic syndrome (MDS) with deletion of the long arm of chromosome 20: A subtype of MDS with distinct hematological and prognostic features? Leuk Res 1993;17:921-926.
22. Pedersen B, Kerndrup G. Specific minor chromosome deletions consistently occurring in myelodysplastic syndromes. Cancer Genet Cytogenet 1986;23:61-75.
23. Ohyashiki K, Murakami T, Ohyashiki JH, et al. Double 20q-anomaly in myelodysplastic syndrome. Cancer Genet Cytogenet 1992;58:174-176.
24. Jotterand-Bellomo M, Parlier V, Schmidt PM, Peris P. Cytogenetic analysis of 54 cases of myelodysplastic syndrome. Cancer Genet Cytogenet 1990;46:152-172.
25. Jacobs RH, Cornbleet MA, Vardiman JW, Larson RA, Le Beau MM, Rowley JD. Prognostic implications of morphology and karyotype in primary myelodysplastic syndromes. Blood 1986;67:1765-1772.
26. Tien H-F, Wang C-H, Chuang S-M, et al. Cytogenetic studies, ras mutation and clincal characteristics in primary myelodysplastic syndrome: A study on 68 Chinese patients in Taiwan. Cancer Genet Cytogenet 1994;74:40-49.
27. Michalova K, Musilova J, Zemanova Z. Consecutive chromosomal studies in patients with myelodysplastic syndrome (MDS). Ann Genet 1991;34:212-218.
28. Cohen MM, Ariel I, Dagan J. Chromosome deletion (46, XY, 20q-) in sideroblastic anemia. Israel J Med Sci 1974;10:1393-1396.
29. Shinohara T, Takuwa N, Morishita K, et al. Chronic myelomonocytic leukemia with a chromosome abnormality (46,XY,20q-) in all dividing myeloid cells: Evidence for clonal origin in a multipotent stem cell common to granulocyte, monocyte, erythrocyte, and thrombocyte. Am J Hematol 1983;15:289-293.
30. Yunis JJ, Rydell RE, Oken MM, Arnesen MA, Mayer MG, Lobell M. Refined chromosome analysis as an independent prognostic indicator in de novo myelodysplastic syndromes. Blood 1986;67:1721-1730.
31. Knapp RH, Dewald GD, Pierre RV. Cytogenetic studies in 174 consecutive patients with preleukemic or myelodysplastic syndromes. Mayo Clin Proc 1985;60:507-516.
32. Yunis J, Lobell M, Arnesen MA, et al. Refined chromosome study helps define prognostic subgroups in most patients with primary myelodysplastic syndrome and acute myelogenous leukaemia. Br J Haemato I 1988;68:189-194.
33. Johansson B, Mertens F, Mitelman F. Secondary chromosomal abnormalities in acute leukemias. Leukemia 1994;8:953-962.
34. Childs CC, Hirsch-Ginsberg C, Walters RS, et al. Myeloid surface antigen-positive acute lymphoblastic leukemia (My+ ALL): Immunophenotypic, ultrastructural, cytogenetic, and molecular characteristics. Leukemia 1989;3:777-783.
35. Testa JR, Kinnealey A, Rowley JD, Golde DW, Potter D. Deletion of the long arm of chromosome 20 [del(20)(qI 1)] in myeloid disorders. Blood 1978;52:868-877.
36. Heim S, Mitleman F. Secondary chromsome aberrations in the acute leukemias. Cancer Genet Cytogenet 1986;22:331-338.
37. Lee EJ, Schiffer CA, Misawa S, Testa JR. Clinical and cytogenetic features of familial erythroleukaemia. Br J Haematol 1987;65: 313-320.
38. Colon-Otero G, Li C-Y, Dewald GW, White WW. Erythrophagocytic acute lymphocytic leukemia with B-cell markers and with a 20q- chromosomal abnormality. Mayo Clin Proc 1984;59: 678-682.
39. Hollings PE, Benjes M, Rosman I. Fitzgerald PH. Deletion 20q in association with Philadelphia chromosome positive acute lymphoblastic leukemia: A report of 2 cases. Cancer Genet Cytogenet 1995;79:32-35.
40. Cotter PD, Tumewu P, Browett PJ. Deletion of the long arm of chromosome 20 in a patient with small cell lymphocytic lymphoma. Cancer Genet Cytogenet 1993;70:142-143.
41. Koduru PRK, Filippa DA, Richardson ME, et al. Cytogenetic and histologic correlations in malignant lymphoma. Blood 1987;69: 97-102.
42. Mark J, Dahlenfors R, Ekedahl C. Recurrent chromosomal aberrations in non-Hodgkin's and non-Burkitt's lymphomas. Cancer Genet Cytogenet 1979;1:39-56.
43. Ueshima Y, Rowley JD, Varikojis D, Winter J, Gordon L. Cytogenetic studies on patients with chronic T-cell leukemia/lymphoma. Blood 1984;63:1028-1038.
44. Schwarz HS, Allen GA, Chudoba I, Butler MG. Cytogenetic abnormalities in a rare case of giant cell osteogenic sarcoma. Cancer Genet Cylogenet 1992;58:60-65.
45. Zankl H, Zang DD. Marker chromosome 20q - does not arise only in bone marrow disorders. Cancer Genet Cytogenet 1981;3:85-87.
46. Hollings PE, Giles LM, Rosman I, Fitzgerald PH. An identical t(Y;1)(q12;q21) in two patients with myelodysplastic syndromes. Cancer Genet Cytogenet 1988;34:285-293.
47. Hakoda M, Hirai Y, Shimba H, et al. Cloning of phenotypically different human lymphocytes originating from a single stem cell. J Exp Med 1989;169:1265-1276.
48. Asimakopoulos FA, White NJ, Nacheva E, Green AR. Molecular analysis of chromosome 20q deletions associated with myeloproliferative disorders and myelodysplastic syndromes. Blood 1994;84:3086-3094.
49. ISCN. An international system for human cytogenetic nomenclature. Birth Defects 1985;21:1-117.
50. Bennett JM, Catovski D, Daniel MT, et al. Proposals for the classification of the myelodysplastic syndromes. Br J Haematol 1982; 51:189-199.
51. Bennett JM, Catovsky D, Daniel MT, et al. Criteria for the diagnosis of acute leukemia of megakaryocyte lineage (M7): A report of the French-American-British Cooperative Group. Ann Intern Med 1985;103:460-462.
52. Bennett JM, Catovsky D, Daniel MT, et al. Proposed revised criteria for the classification of acute myeloid leukemia: A report of the French-American-British Cooperative Group. Ann Intern Med 1985;103:620-625.
53. Bennett JM, Catovsky D, Daniel MT, et al. Proposals for the classification of the acute leukaemias. French-American-British (FAB) co-operative group. Br J Haematol 1976;33:451-458.
54. Berk PD, Goldberg JD, Donovan PB, Fruchtman SM, Berlin NI, Wasserman LR. Therapeutic recommendations in polycythemia vera based on Polycythemia Vera Study Group protocols. Semin Hematol 1986;23:132-143.
55. Murphy S, IIand H, Rosenthal D, Laszlo J. Essential thrombocythemia: An interim report from the Polycythemia Vera Study Group. Semin Hematol 1986;23:177-182.
56. Mitelman F, Kaneko Y, Trent J. Report of the Committee on Chromosome Changes in Neoplasia. Cytogenet Cell Genet 1991;58:1053-1079.
57. Dewald GW, Schad CR, Lila VC, Jalal SM. Frequency and photographs of HGMI 1 chromosome anomalies in bone marrow samples from 3,996 patients with malignant hematologic neoplasms. Cancer Genet Cytogenet 1993;68:60-69.
58. Lacy MQ, Kurtin PJ, Tefferi A. Pure red cell aplasia: Association with large granular lymphocyte leukemia and the prognostic value of cytogenetic abnormalities. Blood 1996; 87:3000-3006.
59. Asimakopoulos FA, Holloway TL, Nacheva EP, Scott MA, Fenaux P, Green AR. Detection of chromosome 20q deletions in bone marrow metaphases but not peripheral blood granulocytes in patients with myeloproliferative disorders or myelodysplastic syndromes. Blood 1996;87:1561-1570.
60. White NJ, Nacheva E, Asimakopoulos FA, Bloxham D, Paul B, Green AR. Deletion of chromosome 20q in myelodysplasia can occur in a multipotent precursor of both myeloid cells and B-cells. Blood 1994;83:2809-2816.
61. Roulston D, Espinosa R, Stoffel M, Bell GI, Le Beau MM. Molecular genetics of myeloid leukemia: Identification of the commonly deleted segment of chromosome 20. Blood 1993;82: 3424-3429.
62. Le Beau MM, Westbrook CA, Diaz MO, Rowley JD. c-src is consistently conserved in the chromosomal deletion (20q) observed in myeloid disorders. Proc Natl Acad Sci USA 1985;82:6692-6696.
63. Morris CM, Honeybone LM, Hollings PE, Fitzgerald PH. Localization of the SRC oncogene to chromosome band 20q 11.2 and loss of this gene with deletion (20q) in two leukemic patients. Blood 1989;74:1768-1773.